Home
Executive Director
Non Executive Director
Chairman & Independent Directo
Non-Exec. & Independent Dir.
Managing Director
NSE: ASTRAZEN
Share Price
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 7030.35 | 7473.95 | 7473.95 | 6868.55 |
13 Jan 2025 | 7043.7 | 6809.8 | 7199.9 | 6769.55 |
10 Jan 2025 | 6912.5 | 7040 | 7040 | 6854.95 |
09 Jan 2025 | 7076 | 6946.9 | 7518.3 | 6946.9 |
08 Jan 2025 | 6892.55 | 7050 | 7069.9 | 6851.2 |
07 Jan 2025 | 7092.85 | 7275.45 | 7384.4 | 7011 |
06 Jan 2025 | 7251.75 | 7173 | 7392.75 | 6910.6 |
03 Jan 2025 | 7113.75 | 7173.95 | 7194.9 | 7009.9 |
02 Jan 2025 | 7137.75 | 7220 | 7220 | 7112 |
01 Jan 2025 | 7206.4 | 7007.05 | 7380.55 | 7007.05 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 7030.35 |
13 Jan 2025 | 7043.7 |
10 Jan 2025 | 6912.5 |
09 Jan 2025 | 7076 |
08 Jan 2025 | 6892.55 |
07 Jan 2025 | 7092.85 |
06 Jan 2025 | 7251.75 |
03 Jan 2025 | 7113.75 |
02 Jan 2025 | 7137.75 |
01 Jan 2025 | 7206.4 |
Market Cap
17,575 Cr
EPS
51.5
P/E Ratio (TTM)
136.5
P/B Ratio (TTM)
25.9
Day’s High
7473.95
Day’s Low
6868.55
DTE
0.0
ROE
18.9
52 Week High
8139.85
52 Week Low
4050.15
ROCE
23.9
1M
1Y
3Y
5Y
Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30
Read more
2024-08-08 00:00:00
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag
Read more
2024-08-08 00:00:00
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
2024-09-24 00:00:00
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini
Read more
2024-09-24 00:00:00